×
0 0 0 0 0.0454545454545455 0 0 -0.0227272727272728
Stockreport

BRIEF-Akari Therapeutics Qtrly Loss Per Common Share $0.01 [Reuters]

AKARI THERAPEUTICS PLC ADR (AKTX)  More Company Research Source: Reuters
US:NASDAQ Investor Relations: investor.akaritx.com/investor-relations
PDF BRIEF-Akari Therapeutics Qtrly Loss Per Common Share $0.01 | Reuters Reuters Staff 1 Min Read March 21 (Reuters) - Akari Therapeutics Plc: * AKARI THERAPEUTICS ANNOUNCES FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND HIGHLIGHTS RECENT CLINICAL PROGRESS * AKARI THERAPEUTICS PLC - CAPSTONE, PHASE III NAAVE PNH TRIAL EXPECTED TO OPEN IN Q1 2018 * AKARI THERAPEUTICS - BASED ON CURRENT CASH POSITION AND OPERATING PLAN, EXPECTS HAS SUFFICIENT CASH TO FUND OPERATIONS INTO Q2 2019 * AKARI THERAPEUTICS PLC - AS OF DECEMBER 31, 2017, COMPANY HAD CASH AND CASH EQUIVALENTS OF $28.1 MILLION * AKARI THERAPEUTICS PLC - QTRLY LOSS PER COMMON SHARE $0.01 Source text for Eikon: Further company coverage: All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays. Š 2018 Reuters. All Rights Reserved. [Read more]

IMPACT SNAPSHOT EVENT TIME: AKTX
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
AKTX alerts

from News Quantified
Opt-in for
AKTX alerts

from News Quantified